Roman Health Ventures

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Roman Health Ventures sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Roman Health Ventures: 1 sponsored US clinical trial, 1 recruiting.

Roman Health Ventures sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Pathology, with 1 trials.

Mid-pack sponsor footprint

Roman Health Ventures is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING

Blood Specimen Collection For Laboratory Assay Research

NCT06046651

Therapeutic Areas

Pathology 1
Hair Loss 1
General; Metabolic Disorder 1
Sexual Dysfunction 1

What is open in the Roman Health Ventures pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Pathology (1 trial), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Roman Health Ventures: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Roman Health Ventures sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Roman Health Ventures1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Roman Health Ventures sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Roman Health Ventures sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Roman Health Ventures page

1 registered trials is a research-attention snapshot, not an endorsement of Roman Health Ventures or any single study.

  • 1 of Roman Health Ventures's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Pathology is the condition Roman Health Ventures studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pathology trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Roman Health Ventures pipeline card: 1 registered trials from official public datasets.Report a data error.